Sepsis Due to Achromobacter xylosoxidans in a Tertiary Care Centre: Case Series

被引:5
作者
Mudey, Gargi [1 ]
Kunjalwar, Radha [1 ]
Sahu, Gaurav [2 ]
Mahajan, Shital M. [1 ]
Meshram, Supriya [1 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Dept Microbiol, Wardha, India
[2] Datta Meghe Inst Higher Educ & Res, Wardha, India
关键词
immunocompromised patient; multi-drug resistant; gram-negative organism; bacteremia; achromobacter xylosoxidans; BACTEREMIA;
D O I
10.7759/cureus.42052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Achromobacter xylosoxidans, also known asAlcaligenes xylosoxidans, is a low-virulence, non-fermenter gram -negative bacillus mainly found in marine environments. We report a detailed series of four high-risk cases of septicemia with the common variable of positive blood cultures for A. xylosoxidans. All four blood isolates were multi-drug resistant and susceptible to meropenem and trimethoprim-sulfamethoxazole. Two patients responded well to the treatment with meropenem and trimethoprim-sulfamethoxazole and two patients died. It should never be assumed that Achromobacter is a contaminant even though it is relatively infrequently isolated from clinical samples. This infection can progress to fatal bacteremia, even in otherwise healthy people, and it can potentially cause severe conditions in premature infants. With only a limited number of antibiotics demonstrating bactericidal properties, the possibility of failure in empirical treatment is significant. As a result, it is important to have a precise comprehension of this uncommon yet deadly illness in order to increase the probability of successful treatment.
引用
收藏
页数:13
相关论文
共 11 条
  • [1] In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods
    Almuzara, Marisa
    Limansky, Adriana
    Ballerini, Viviana
    Galanternik, Laura
    Famiglietti, Angela
    Vay, Carlos
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (01) : 68 - 71
  • [2] Achromobacter xylosoxidans Bacteremia in a Liver Transplant Patient: A Case Report and Literature Review
    Barakat, Munsef
    Sajid, Jamal
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [3] Two unique presentations of Achromobacter xylosoxidans infections in clinical settings
    Eshwara, Vandana Kalwaje
    Mukhopadhyay, Chiranjay
    Mohan, Savitha
    Prakash, Rajath
    Pai, Ganesh
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2011, 5 (02): : 138 - 141
  • [4] Achromobacter xylosoxidans bacteremia:: A 10-year analysis of 54 cases
    Gómez-Cerezo, J
    Suárez, I
    Ríos, JJ
    Peña, P
    de Miguel, MJG
    de José, M
    Monteagudo, O
    Linares, P
    Barbado-Cano, A
    Vázquez, JJ
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (06) : 360 - 363
  • [5] Achromobacter xylosoxidans/denitrificans bacteremia and subsequent fatal Escherichia coli/Streptococcus anginosus pleural empyema
    Habib, Saad
    Fuca, Nicholas
    Azam, Mohammed
    Siddiqui, Abdul Hasan
    Rajdev, Kartikeya
    Chalhoub, Michel
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2018, 25 : 311 - 313
  • [6] Otta S., 2014, JMM CASE REP, V1
  • [7] Raghuraman Kausalya, 2015, J Lab Physicians, V7, P124, DOI 10.4103/0974-2727.163133
  • [8] Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
    Turel, Ozden
    Kavuncuoglu, Sultan
    Hosaf, Emine
    Ozbek, Sibel
    Aldemir, Esin
    Uygur, Turkan
    Hatipoglu, Nevin
    Siraneci, Rengin
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (04) : 450 - 454
  • [9] Ucciferri C, 2021, J Bacteriol Mycol, V8, DOI [10.26420/jbacteriolmycol.2021.1169, DOI 10.26420/JBACTERIOLMYCOL.2021.1169]
  • [10] Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients
    Wellinghausen, Nele
    Wirths, Beate
    Poppert, Sven
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) : 3415 - 3417